Skip to content
Back to Guavy Wire
Stocks

Kennedy's Vaccine Stake Raises Questions as Senators Demand Answers

Instruments
MRK
Share

US Health Secretary Robert F. Kennedy Jr. is under fire for his handling of a financial stake in litigation involving Merck's Gardasil vaccine. In a letter to Kennedy, four Democratic senators questioned his recent explanation of how he disposed of the stake, which conflicts with earlier answers he gave in written testimony and federal ethics filings.

The senators pointed out that Merck agreed to pay $50 million to settle litigation over Gardasil this year. Before becoming health secretary last year, Kennedy was an attorney of record in some of the cases. He initially said he intended to keep a 10% fee of any settlement involving Gardasil cases he referred to the Wisner Baum law firm.

Kennedy later claimed that he would hand over his financial interest in vaccine litigation to his son, and accused lawmakers and media outlets of 'inventing lies' to besmirch him. However, the senators said Kennedy's recent statement appears to indicate that earlier information was no longer accurate.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc